Clinical Trials

308 enrolled

Leukemia, Myeloid, Acute

NCT07407140 2026-03-25

VAG-3+7-G

300 enrolled

Leukemia, Myeloid, Acute

NCT07486479 2026-03-20

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

204 enrolled

Leukemia, Myeloid, Acute

NCT07478991 2026-03-18

VENP-A-QUI

376 enrolled

Leukemia, Myeloid, Acute

NCT07132684 2026-03-02

Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

Phase 3 Recruiting

240 enrolled

Leukemia, Myeloid, Acute

NCT07407660 2026-02-12

Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax

250 enrolled

Leukemia, Myeloid, Acute

NCT06647862 2025-11-25

IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)

Phase 3 Recruiting

170 enrolled

Leukemia, Myelomonocytic, Chronic

NCT07082452 2025-07-24

SEVENAZA

LymphoidOther hematologic neoplasm

262 enrolled

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

86 enrolled

Myeloid

Higher-risk Myelodysplastic Syndrome

NCT03765541 2025-04-10

DEXAML-03

Phase 3 Terminated

73 enrolled

Phase 3 Active not recruiting

Recurrence, Leukemia, Myeloid, Acute

NCT04090736 2025-03-17

PEVOLAM

302 enrolled

Phase 3 Active not recruiting

Leukemia, Leukemia, Myeloid, Acute

NCT04173533 2024-05-14

AMADEUS

326 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT06345365 2024-04-10

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase 3 Recruiting

154 enrolled

Leukemia, Myeloid, Acute

NCT06073730 2023-10-10

Viale-a

154 enrolled

Leukemia, Myeloid, Acute

NCT05188326 2023-06-08

Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients

Phase 3 Completed

54 enrolled

Leukemia, Myeloid, Acute

NCT05457361 2022-07-14

VAH Versus VA for Salvage Therapy of R/R-AML

162 enrolled

Leukemia, Myeloid, Acute

NCT04490707 2022-03-24

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

60 enrolled

Leukemia, Myeloid, Acute

NCT04722952 2021-12-03

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

30 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT00887068 2020-01-14

Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)

Phase 3 Completed

187 enrolled 9 charts

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01067274 2015-12-30

ALFA-0703

Phase 3 Withdrawn